| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |